Related Experiment Videos
Static magnetic fields alter arteriolar tone in vivo
Cassandra Morris1, Thomas Skalak
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Bioelectromagnetics
|December 18, 2004
Summary
Static magnetic field (SMF) exposure normalized microvascular tone in rat skeletal muscle. Smaller, vasodilated vessels constricted, while smaller, vasoconstricted vessels dilated, suggesting SMF may treat circulatory disorders.
Area of Science:
- Physiology
- Biophysics
- Medical Engineering
Background:
- Microvascular dysfunction contributes to various tissue disorders.
- Static magnetic fields (SMF) have shown potential therapeutic effects, but their direct impact on microvessels requires clarification.
Purpose of the Study:
- To quantify the in vivo effect of localized static magnetic field (SMF) exposure on arteriolar diameter and microvascular tone in rat skeletal muscle.
- To investigate if SMF exposure influences microvessels in a diameter- and tone-dependent manner.
Main Methods:
- Adult rat spinotrapezius microvasculature was exteriorized and exposed to a 70 mT SMF for 15 minutes.
- Arteriolar diameters were measured to calculate microvascular tone before, during, and after SMF application.
- Vessels were categorized by initial diameter (<30 µm vs. >30 µm) and initial tone (<15% vs. >15%).
Main Results:
- SMF exposure modulated microvascular tone, tending to normalize it towards a median value of 15%.
- Smaller vessels (<30 µm) initially vasodilated (<15% tone) showed increased tone (constriction) post-SMF.
- Smaller vessels (<30 µm) initially vasoconstricted (>15% tone) showed decreased tone (vasodilation) 30 minutes post-SMF.
- Larger vessels (>30 µm) exhibited no significant response to SMF.
Conclusions:
- SMF exposure influences arteriolar diameter and microvascular tone in a restorative manner, normalizing tone.
- This effect is primarily observed in smaller resistance arterioles, which are critical for tissue perfusion.
- SMF application holds potential efficacy for treating ischemic and edematous tissue disorders characterized by compromised microvascular function.